These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16702599)

  • 21. Code could be right prescription to give pharmacy more credence.
    La Puma J
    Manag Care; 1998 Dec; 7(12):44-5. PubMed ID: 10344809
    [No Abstract]   [Full Text] [Related]  

  • 22. Methodological concerns in a trial of ziprasidone and olanzapine.
    Ross DE
    Am J Psychiatry; 2005 Jul; 162(7):1391; author reply 1391-2. PubMed ID: 15994735
    [No Abstract]   [Full Text] [Related]  

  • 23. Minimizing bias in industry-sponsored outcomes research.
    Freeman RA
    Med Interface; 1994 Apr; 7(4):130-4. PubMed ID: 10133357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impugning the integrity of medical science: the adverse effects of industry influence.
    DeAngelis CD; Fontanarosa PB
    JAMA; 2008 Apr; 299(15):1833-5. PubMed ID: 18413880
    [No Abstract]   [Full Text] [Related]  

  • 25. PMAC code of marketing practices.
    Lexchin J
    CMAJ; 1999 Jun; 160(11):1556. PubMed ID: 10447368
    [No Abstract]   [Full Text] [Related]  

  • 26. [Marketing of the LIFE trial anticipates evaluation of the drug].
    Järhult B
    Lakartidningen; 2002 Apr; 99(17):1964. PubMed ID: 12043424
    [No Abstract]   [Full Text] [Related]  

  • 27. Mandatory registration of clinical trials: a major step forward for evidence-based medicine.
    Kimball AB; Weinstock MA
    J Am Acad Dermatol; 2005 May; 52(5):890-2. PubMed ID: 15858483
    [No Abstract]   [Full Text] [Related]  

  • 28. The stain wars.
    Olsson GO; Blasetto JW; Bryzinski BS; Caplan RJ; Gold A
    Lancet; 2003 Nov; 362(9398):1855-6; discussion 1856. PubMed ID: 14654329
    [No Abstract]   [Full Text] [Related]  

  • 29. The importance of preservation of the ethical principle of equipoise in the design of clinical trials: relative impact of the methodological quality domains on the treatment effect in randomized controlled trials.
    Djulbegovic B; Cantor A; Clarke M
    Account Res; 2003; 10(4):301-15. PubMed ID: 14989285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On transparency, responsibility, and accountability.
    Paul M
    Clin Microbiol Infect; 2009 Dec; 15(12):1100-2. PubMed ID: 19929974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stopping a trial early in oncology: for patients or for industry?
    Whitehead J; Cobo E
    Ann Oncol; 2008 Aug; 19(8):1512-1513. PubMed ID: 18621741
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical trial protocols: agreements between the FDA and industrial sponsors.
    Mann H
    Lancet; 2002 Nov; 360(9343):1345-6. PubMed ID: 12423978
    [No Abstract]   [Full Text] [Related]  

  • 33. A cross-sectional evidence-based review of pharmaceutical promotional marketing brochures and their underlying studies: is what they tell us important and true?
    Cardarelli R; Licciardone JC; Taylor LG
    BMC Fam Pract; 2006 Mar; 7():13. PubMed ID: 16515686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimizing the influence of drug marketing.
    Hester FG
    Hospitals; 1990 Aug; 64(15):80. PubMed ID: 2373503
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug detailing in the hospital: background for policy development.
    Chan J; Einarson T
    Can J Hosp Pharm; 1991 Jun; 44(3):161-6. PubMed ID: 10112744
    [No Abstract]   [Full Text] [Related]  

  • 36. How skeptical should we be about industry-sponsored studies?
    Meador KJ
    Neurology; 2007 Apr; 68(15):1238; author reply 1238. PubMed ID: 17420417
    [No Abstract]   [Full Text] [Related]  

  • 37. Publish or be damned.
    Vines G
    New Sci; 1997 Sep; 155(2099):53. PubMed ID: 16127834
    [No Abstract]   [Full Text] [Related]  

  • 38. New paradigm for drug developments--from emerging market statistical perspective.
    Quan H; Chen X; Zhang J; Zhao PL
    Contemp Clin Trials; 2013 Nov; 36(2):697-703. PubMed ID: 23810938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of reporting controlled clinical trials on treatment of the acute mania phase of bipolar disorder with new antipsychotic drugs.
    Arbaizar B; Gómez-Acebo I; Llorca J
    Pharmacopsychiatry; 2008 Nov; 41(6):240-1. PubMed ID: 19067261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ethical code of the pharmaceutical industry in Slovakia. (Excerpts).
    Med Etika Bioet; 2004; 11(3-4):11-22. PubMed ID: 16294449
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.